Abstract: In a cooling system for electronic apparatuses, the electronic apparatus includes inner partitioning walls disposed in a cooling tank with an open space, defined by a bottom wall and side walls for dividing the open space into arrayed storage sections. An electronic apparatus is stored in the storage section. Inflow openings for the cooling liquid are formed in a bottom portion or a side surface of the respective storage sections, and outflow openings are formed at a position near the liquid surface of the cooling liquid flowing in the respective storage sections. The electronic apparatus includes a first board having a first surface on which at least one processor is mounted, and a second surface opposite the first surface, a second board having the third surface that faces the second surface of the first board, and a flow channel formed as a gap between the second and third surface.

Abstract: Provided is a cooling system capable of improving the cooling performances of a plurality of electronic apparatuses, of making stabilization by eliminating the variance in the cooling performances and of being improved in the handling and maintainability of the electronic apparatuses. A plurality of inner partitioning walls are provided in a cooling tank having an open space defined by a bottom wall and side walls to divide the open space, and a plurality of arrayed storage sections are defined. An electronic apparatus is stored in each of the storage sections. Each of the storage sections is formed with an inflow opening and an outflow opening for the cooling liquid. The inflow opening is formed at a bottom portion or a side surface of each storage section, and the outflow opening is formed in the vicinity of the liquid level of the cooling liquid flowing through each storage section.

Abstract: There are provided a cooling system and a cooling method that are simple and efficient and improve cooling performances for an electronic device. A cooling system (10) includes a cooling bath (12). In the open space of the cooling bath (12), a second coolant (13) with a boiling point (T2) is contained. In the open space of the cooling bath (12), an electronic device (100) is housed. The electronic device (100) is mounted with a processor (110) as a heat generating component on a board (120). The electronic device (100) is immersed in the second coolant 13. A boiling cooling device (200) is a cooling device thermally connected to the processor (110), and encloses a first coolant 11 with a boiling point (T1) (where T2>T1).

Abstract: A cooling system is adapted for reduction of evaporative loss of a liquid coolant and for efficient cooling of plural electronic devices densely accommodated in a cooling bath of a small volume. A cooling system accommodates plural electronic devices in an open space of a cooling bath provided with an inlet port and an outlet port for a liquid coolant. The cooling system is configured to directly cool the electronic devices by immersion of the electronic devices in the liquid coolant circulated in the open space. The liquid coolant contains a perfluorinated compound as a main component. The liquid coolant is adapted to exhibit a liquid weight loss percentage of 1.5% or less as determined by allowing 10 ml of the liquid coolant in a 10-ml measuring cylinder (opening diameter: 11.5 mm) to spontaneously evaporate under normal environment at a room temperature of 25° C. for 100 hours.

Abstract: According to one embodiment, workflow templates are maintained, each workflow template including a predefined sequence of workflow stages associated with a particular type of medical diagnosis or process. In response to a request for processing medical image data from a user, a user identifier (ID) that identifies the user is automatically determined based on the request. At least one of the workflow templates that is specifically configured to process medical image data associated with the user is identified based on the user ID. One or more image processing operations defined by the identified workflow template are performed on the medical image data, generating a scene corresponding to an image view representing the medical image data. The scene associated with each of the workflow stages is stored in a persistent storage, where a scene includes metadata used to recreate a corresponding medical image view subsequently.

Abstract: According to one embodiment, workflow templates are stored, each including a predefined sequence of workflow stages associated with a particular type of medical diagnosis or process. Each workflow stage defines one or more image processing operations to be performed. At least one workflow stage generates metadata specifying a parameter to be used by another workflow stage for processing a corresponding medical image. In response to medical image data received, at least one of the image processing operations defined by the workflow stages is performed on the medical image data. A scene is generated for each of the workflow stages representing an image view representing the medical image data. In response to a save or validate command received from a user, the scene associated with each of the workflow stages is stored in a persistent storage, which can be used to recreate a corresponding medical image view subsequently.

Abstract: An optical glass in includes SiO2, B2O3, Al2O3, BaO, CaO, ZnO, La2O3, Gd2O3, and Y2O3, each in a specific ratio. Further, the optical glass satisfies the following conditional expressions (1) and (2), taking the content of SiO2 as A, the content of B2O3 as B, the content in total of La2O3, Gd2O3 and Y2O3 as C, and the content in total of SiO2 and B2O3 as D. 0.35<A/B<0.70??(1) 0.80<C/D<1.0??(2) By the above constitution, a high refractive index and low dispersibility are secured and at the same time deformation temperature (and glass transition temperature) lowers. By containing Al2O3, the glass structure is stabilized and a failure in appearance such as cloudiness in press molding is difficult to occur.

Abstract: Some embodiments of a workflow management system to process medical image data generated by a medical imaging device have been presented. In one embodiment, a user selects a workflow template with a predefined set of image processing stages, and applies the workflow template to the medical image data. Each of the predefined set of image processing stages in the workflow template includes one or more image processing operations. Each of the image processing operations is capable of generating metadata for processing the medical image data. The medical image data is then processed through each of the predefined image processing stages. The result of processing is a collection of metadata. Each metadata in the collection can be applied to the medical image data to generate a medical image view.

Abstract: The present invention relates to an agent for improving renal dysfunction comprising as an active ingredient a compound represented by the following formula (1): wherein each R1, R2, and R3 represents a hydrogen atom or a methyl group, and X represents a linear or branched alkylene or alkenylene group having 10 to 28 carbon atoms.

Abstract: An optical glass includes, by weight: 1% or more and 5% or less of silicon oxide (SiO2); 15% or more and 24% or less of boron oxide (B2O3); 0.1% or more and 3% or less of aluminum oxide (Al2O3); 1% or more and 14% or less of zinc oxide (ZnO); 35% or more and 45% or less of lanthanum oxide (La2O3); 5% or more and 10% or less of yttrium oxide (Y2O3); 5% or more and 13% or less of tantalum oxide (Ta2O5); and 0.5% or more and 3% or less of lithium oxide (Li2O).

Abstract: An optical glass in includes SiO2, B2O3, Al2O3, BaO, CaO, ZnO, La2O3, Gd2O3, and Y2O3, each in a specific ratio. Further, the optical glass satisfies the following conditional expressions (1) and (2), taking the content of SiO2 as A, the content of B2O3 as B, the content in total of La2O3, Gd2O3 and Y2O3 as C, and the content in total of SiO2 and B2O3 as D. 0.35<A/B<0.70??(1) 0.80<C/D<1.0??(2) By the above constitution, a high refractive index and low dispersibility are secured and at the same time deformation temperature (and glass transition temperature) lowers. By containing Al2O3, the glass structure is stabilized and a failure in appearance such as cloudiness in press molding is difficult to occur.

Abstract: A preventive and/or therapeutic agent for diabetes complications, which comprises as an effective ingredient a cyclohexenone long-chain alcoholic derivative represented by the following formula (1): wherein, R1, R2 and R3 each independently represents a hydrogen atom or a methyl group and X represents a linear or branched C10-28 alkylene or alkenylene group. The cyclohexenone long-chain alcoholic derivative of the present invention significantly suppresses a reduction in a peripheral nerve conduction rate and alleviates the hypofunction of the bladder so that it is useful as a preventive and/or therapeutic agent for diabetes complications, particularly, for diabetic neuropathy.

Abstract: An optical glass includes, by weight: 1% or more and 5% or less of silicon oxide (SiO2); 15% or more and 24% or less of boron oxide (B2O3); 0.1% or more and 3% or less of aluminum oxide (Al2O3); 1% or more and 14% or less of zinc oxide (ZnO); 35% or more and 45% or less of lanthanum oxide (La2O3); 5% or more and 10% or less of yttrium oxide (Y2O3); 5% or more and 13% or less of tantalum oxide (Ta2O5); and 0.5% or more and 3% or less of lithium oxide (Li2O).

Abstract: Disclosed is an optical glass having a high refractive index and high moldability. An optical glass according to an embodiment of the invention includes Bi2O3, B2O3, SiO2, Al2O3, and ZnO and satisfies the following Conditional expressions 1 and 2: X+Y?75 ??(1), and 2.5<X/Y<13 ??(2) where X indicates the content (wt %) of Bi2O3 and Y indicates the content (wt %) of B2O3. When Conditional expression 1 is satisfied, it is possible to avoid crystallization and ensure high transparency. If the ratio is greater than the lower limit of Conditional expression 2, the refractive index nd of the optical glass with respect to the d-line is equal to or greater than 1.9. If the ratio is less than the upper limit of Conditional expression 2, it is easy to perform vitrification.

Abstract: Some embodiments of a workflow management system to process medical image data generated by a medical imaging device have been presented. In one embodiment, a user selects a workflow template with a predefined set of image processing stages, and applies the workflow template to the medical image data. Each of the predefined set of image processing stages in the workflow template includes one or more image processing operations. Each of the image processing operations is capable of generating metadata for processing the medical image data. The medical image data is then processed through each of the predefined image processing stages. The result of processing is a collection of metadata. Each metadata in the collection can be applied to the medical image data to generate a medical image view.

Abstract: A system is provided wherein data processing devices are connected to a high-speed picture archiving and communications system (PACS) server network that archives and transmits medical image data. As part of a diagnostic process, medical images are processed at the data processing devices and image processing parameter (IPP) sets are created. The image processing parameters are attached to image diagnosis reports and can be used to recreate the processing of key images that are referenced in the image diagnosis reports. Users of the diagnostic reports can send the IPP sets to the PACS server network to recreate and retrieve key diagnostic images. The image data can be compressed for transmission over low bandwidth networks.

Abstract: The present invention provides preventive and/or therapeutic agents for either one, or both, of a diabetic vascular disorder and a diabetic respiratory disorder comprising, as an active ingredient, a cyclohexenone long chain alcohol compound represented by the following formula (1): [wherein R1, R2, and R3 each represent a hydrogen atom or a methyl group, and X represents a linear or branched C10-C28 alkylene or alkenylene group]. Since the cyclohexenone long chain alcohol of formula (1) improves diabetic vascular smooth muscle contraction and bronchial smooth muscle contraction, it is useful as a preventive and/or therapeutic agent for a diabetic vascular disorder or a respiratory disorder.

Abstract: An optical glass comprises: germanium oxide (GeO2) content of 14 wt % to 21 wt %; niobium oxide (Nb2O5) content of 14 wt % to 23 wt %; bismuth oxide (Bi2O3) content of 40 wt % to 52 wt %; tungsten oxide (WO3) content of 0 wt % to 5 wt %; phosphoric acid (P2O5) content of 7 wt % to 14 wt %; potassium oxide (K2O) content of 0 wt % to 4 wt %; barium oxide (BaO) content of 0 wt % to 5 wt %; lithium oxide (Li2O) content of 0 wt % to 3 wt %; sodium oxide (Na2O) content of 0 wt % to 2 wt %; and titanium oxide (TiO2) content of 1 wt % to 5 wt %, wherein iron (Fe) content is less than 10 ppm based on the total weight of the titanium oxide.

Abstract: The present invention relates to an agent for improving renal dysfunction comprising as an active ingredient a compound represented by the following formula (1): wherein each R1, R2, and R3 represents a hydrogen atom or a methyl group, and X represents a linear or branched alkylene or alkenylene group having 10 to 28 carbon atoms.

Abstract: In a system in which data processing devices are set up in the vicinity of or directly connected to data archiving devices of a plurality of medical image systems, image data and image processing parameters are specified from user terminal devices connected to the network. Image data specified by data processing devices is acquired, specified image processing operations are performed and the results of the image processing are sent to user terminal devices. The user terminal devices receive results of image processing from multiple data processing devices, image processing operations such as superimposition and fusion are conducted, and the results are displayed. Image processing operations therefore can be applied to image data stored in data archiving devices of multiple facilities for medical treatment using data processing devices in the vicinity without acquisition through the network.